Identification of a sub-population of B cells that proliferates after infection with epstein-barr virus

Virology Journal

Volumn 8, Issue , 2011, Pages

  Megyola, Cynthia ^a   Ye, Jianjiang ^a,b   Bhaduri Mcintosh, Sumita ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fei Tian Academy of the Arts   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE GROWTH FACTOR; CD23 ANTIGEN; CYTOKINE; INTERLEUKIN 6; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; IMMUNOGLOBULIN E RECEPTOR;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS INFECTION; EX VIVO STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MEMORY CELL; NONHUMAN; NORMAL HUMAN; PROTEIN EXPRESSION; VIRUS GENE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; EPSTEIN BARR VIRUS; FEMALE; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 4;

B-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE EXPRESSION; HERPESVIRUS 4, HUMAN; HUMANS; INTERLEUKIN-6; MALE; RECEPTORS, IGE;

EID: 79951953475     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-84     Document Type: Article

References (40)

1. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. RJ Tierney N Steven LS Young AB Rickinson, J Virol 1994 68 7374 7385 7933121 (Pubitemid 24328793)
2. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. GJ Babcock D Hochberg AD Thorley-Lawson, Immunity 2000 13 497 506 10.1016/S1074-7613(00) 00049-2 11070168
3. Cells expressing the Epstein-Barr virus growth program are present in and restricted to the naive B-cell subset of healthy tonsils. AM Joseph GJ Babcock DA Thorley-Lawson, J Virol 2000 74 9964 9971 10.1128/JVI.74.21.9964-9971.2000 11024124
4. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. JA Thomas NA Hotchin MJ Allday P Amlot M Rose M Yacoub DH Crawford, Transplantation 1990 49 944 953 10.1097/00007890-199005000-00022 2159663 (Pubitemid 20171966)
5. Altered growth phenotype of a Burkitt's lymphoma line following the introduction and stable expression of the EBNA 2A gene. J Gordon MJ Millsum M Finney JA Cairns GR Guy CD Gregory SD Abbot AB Rickinson F Wang E Kieff, Curr Top Microbiol Immunol 1988 141 149 156 3215047
6. Early events in Epstein-Barr virus infection provide a model for B cell activation. DA Thorley-Lawson KP Mann, J Exp Med 1985 162 45 59 10.1084/jem.162.1.45 2989413 (Pubitemid 15029886)
7. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. DA Thorley-Lawson LM Nadler AK Bhan RT Schooley, J Immunol 1985 134 3007 3012 2984280 (Pubitemid 15249813)
8. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. D Wang D Liebowitz E Kieff, J Virol 1988 62 2337 2346 2836616
9. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. D Wang D Liebowitz F Wang C Gregory A Rickinson R Larson T Springer E Kieff, J Virol 1988 62 4173 4184 2845129
10. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. F Wang C Gregory C Sample M Rowe D Liebowitz R Murray A Rickinson E Kieff, J Virol 1990 64 2309 2318 2157887 (Pubitemid 20148479)
11. B cell activation and the establishment of Epstein-Barr virus latency. EA Hurley DA Thorley-Lawson, J Exp Med 1988 168 2059 2075 10.1084/jem.168.6.2059 2848918 (Pubitemid 19020889)
12. Efficiency of transformation of lymphocytes by Epstein-Barr virus. E Henderson G Miller J Robinson L Heston, Virology 1977 76 152 163 10.1016/0042-6822(77)90292-6 189490 (Pubitemid 8031103)
13. Clonal transformation of adult human leukocytes by Epstein-Barr virus. B Sugden W Mark, J Virol 1977 23 503 508 197258 (Pubitemid 8172767)
14. Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infection. ML Roberts AT Luxembourg NR Cooper, J Gen Virol 1996 77 Pt 12 3077 3085 10.1099/0022-1317-77-12-3077 9000100
15. Epstein-Barr virus-induced B-cell transformation: quantitating events from virus binding to cell outgrowth. C Shannon-Lowe G Baldwin R Feederle A Bell A Rickinson HJ Delecluse, J Gen Virol 2005 86 3009 3019 10.1099/vir.0.81153-0 16227222 (Pubitemid 41555565)
16. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. DA Thorley-Lawson A Gross, N Engl J Med 2004 350 1328 1337 10.1056/NEJMra032015 15044644 (Pubitemid 38375368)
17. CD27: a memory B-cell marker. K Agematsu S Hokibara H Nagumo A Komiyama, Immunol Today 2000 21 204 206 10.1016/S0167-5699(00)01605-4 10782048 (Pubitemid 30259022)
18. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. U Klein K Rajewsky R Kuppers, J Exp Med 1998 188 1679 1689 10.1084/jem.188.9.1679 9802980 (Pubitemid 28516113)
19. BN Fields DM Knipe PM Howley, Fundamental virology Philadelphia: Lippincott-Raven 3 1996
20. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. G Tosato J Tanner KD Jones M Revel SE Pike, J Virol 1990 64 3033 3041 2159561 (Pubitemid 20171296)
21. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. T Yokoi T Miyawaki A Yachie K Kato Y Kasahara N Taniguchi, Immunology 1990 70 100 105 2162322 (Pubitemid 20148070)
22. EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. J Kurth T Spieker J Wustrow GJ Strickler LM Hansmann K Rajewsky R Kuppers, Immunity 2000 13 485 495 10.1016/S1074-7613(00)00048-0 11070167
23. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein. SD Abbot M Rowe K Cadwallader A Ricksten J Gordon F Wang L Rymo AB Rickinson, J Virol 1990 64 2126 2134 2157875 (Pubitemid 20148457)
24. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. E Johannsen E Koh G Mosialos X Tong E Kieff SR Grossman, J Virol 1995 69 253 262 7983717 (Pubitemid 24378801)
25. Patterns of cytokine gene expression in infectious mononucleosis. HD Foss H Herbst M Hummel I Araujo U Latza C Rancso F Dallenbach H Stein, Blood 1994 83 707 712 8298133 (Pubitemid 24043731)
26. Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6. S Mauray MT Fuzzati-Armentero P Trouillet M Ruegg G Nicoloso M Hart L Aarden M Schapira MA Duchosal, Eur J Immunol 2000 30 2065 2073 10.1002/1521-4141(200007)30:7<2065::AID-IMMU2065>3.0.CO;2-W 10940896 (Pubitemid 30456203)
27. Interleukin-6 production in posttransplant lymphoproliferative disease. G Tosato K Jones MK Breinig HP McWilliams JL McKnight, J Clin Invest 1993 91 2806 2814 10.1172/JCI116523 8514888 (Pubitemid 23182539)
28. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. MJ Allday DH Crawford BE Griffin, J Gen Virol 1989 70 Pt 7 1755 1764 10.1099/0022-1317-70-7-1755 2544663 (Pubitemid 19170211)
29. A novel form of Epstein-Barr virus latency in normal B cells in vivo. EM Miyashita B Yang KM Lam DH Crawford DA Thorley-Lawson, Cell 1995 80 593 601 10.1016/0092-8674(95)90513-8 7532548
30. A subpopulation of normal human peripheral B lymphcytes that bind IgE. A Gonzalez-Molina HL Spiegelberg, J Clin Invest 1977 59 616 624 10.1172/JCI108679 321474 (Pubitemid 8073822)
31. Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. H Kikutani M Suemura H Owaki H Nakamura R Sato K Yamasaki EL Barsumian RR Hardy T Kishimoto, J Exp Med 1986 164 1455 1469 10.1084/jem.164.5.1455 2945890 (Pubitemid 17184181)
32. Expression of CD27 and CD23 on peripheral blood B lymphocytes in humans of different ages. D Veneri R Ortolani M Franchini G Tridente G Pizzolo A Vella, Blood Transfus 2009 7 29 34 19290077
33. Immortalization of Epstein-Barr virus-infected CD23-negative B lymphocytes by the addition of B cell growth factor. T Azim MJ Allday DH Crawford, J Gen Virol 1990 71 Pt 3 665 671 10.1099/0022-1317-71-3-665 2155999 (Pubitemid 20111912)
34. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation. S Nikiforow K Bottomly G Miller, J Virol 2001 75 3740 3752 10.1128/JVI.75.8.3740-3752.2001 11264363 (Pubitemid 32246383)
35. Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection. T Felzmann V Witt D Wimmer G Ressmann D Wagner P Paul K Huttner G Fritsch, Cytotherapy 2003 5 391 398 10.1080/14653240310003053 14578101 (Pubitemid 37369026)
36. An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes. HM Oh JM Oh SC Choi SW Kim WC Han TH Kim DS Park CD Jun, Cell Prolif 2003 36 191 197 10.1046/j.1365-2184.2003.00276.x 12950388
37. Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. W Henle GE Henle CA Horwitz, Hum Pathol 1974 5 551 565 10.1016/S0046-8177(74) 80006-7 4368691
38. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. BJ Quah HS Warren CR Parish, Nat Protoc 2007 2 2049 2056 10.1038/nprot.2007.296 17853860 (Pubitemid 351565842)
39. Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data. ED Hawkins M Hommel ML Turner FL Battye JF Markham PD Hodgkin, Nat Protoc 2007 2 2057 2067 10.1038/nprot.2007.297 17853861 (Pubitemid 351565843)
40. B cell differentiation and isotype switching is related to division cycle number. PD Hodgkin JH Lee AB Lyons, J Exp Med 1996 184 277 281 10.1084/jem.184.1.277 8691143 (Pubitemid 26247238)